Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg [Phase 4]

View source ↗

Summary

Phase 4 trial update for EsoDuo Tab. 20/800mg evaluating efficacy and safety in non-erosive reflux disease (NERD) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• EsoDuo Tab. 20/800mg

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Non-erosive Reflux Disease(NERD) | Phase 4 | Status: COMPLETED